Identification of targeted therapy options for gastric adenocarcinoma by comprehensive analysis of genomic data.

Authors:
Hescheler DA; Plum PS; Zander T; Quaas A; Korenkov M and 4 more

Journal:
Gastric Cancer

Publication Year: 2020

DOI:
10.1007/s10120-020-01045-9

PMCID:
PMC7305081

PMID:
32107691

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Gastric Cancer

Abbreviation: Gastric Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metas…
Kang YK; Ryu MH; Di Bartolomeo M and 15 more (2024) - Transparency Score: 4/6
Sustained exposure to Helicobacter pylori induces immune tolerance by desensitizing TLR6.
Zhang X; He Y; Zhang X and 15 more (2024) - Transparency Score: 3/6
Artificial intelligence-guided discovery of gastric cancer continuum.
Vo D; Ghosh P; Sahoo D. (2023) - Transparency Score: 4/6
Circulating hormones and risk of gastric cancer by subsite in three cohort studies.
Sanikini H; Biessy C; Rinaldi S and 12 more (2023) - Transparency Score: 3/6
Effect of preoperative chemotherapy on the histopathological classification of gastric cancer.
Caspers IA; Biesma HD; Wiklund K and 11 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest We declare that we have no conflicts of interest."

Evidence found in paper:

"Funding None."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025